Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...